Page last updated: 2024-09-04

fenton's reagent and ER-Negative PR-Negative HER2-Negative Breast Cancer

fenton's reagent has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Z; Ding, Q; Du, Y; Lee, JY; Li, F; Liao, H; Lin, P; Ling, D; Wang, N; Yang, C; Zhou, Y1

Other Studies

1 other study(ies) available for fenton's reagent and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Core-Shell-Satellite Nanomaces as Remotely Controlled Self-Fueling Fenton Reagents for Imaging-Guided Triple-Negative Breast Cancer-Specific Therapy.
    Small (Weinheim an der Bergstrasse, Germany), 2020, Volume: 16, Issue:31

    Topics: Cell Line, Tumor; Humans; Hydrogen Peroxide; Iron; Phosphatidylinositol 3-Kinases; Triple Negative Breast Neoplasms

2020